Episodes 1-15 of 435
Finerenone vs Placebo in Type 1 Diabetes and CKD: Updates From the Phase 3 FINE-ONE Trial From the Kidney Meeting 2025 in Houston
NephrologyFinerenone vs Placebo in Type 1 Diabetes and CKD: Updates From the Phase 3 FINE-ONE Trial From the Kidney Meeting 2025 in Houston
Implications of the FINE-ONE Trial: How Might Recently Presented Data From the 2025 Kidney Meeting Influence the Current Treatment Paradigm for Type 1 Diabetes and CKD?
NephrologyImplications of the FINE-ONE Trial: How Might Recently Presented Data From the 2025 Kidney Meeting Influence the Current Treatment Paradigm for Type 1 Diabetes and CKD?
New Data From the CONFIDENCE Trial: The Effect of Combination Empagliflozin and Finerenone on UACR and eGFR in CKD and Type 2 Diabetes
NephrologyNew Data From the CONFIDENCE Trial: The Effect of Combination Empagliflozin and Finerenone on UACR and eGFR in CKD and Type 2 Diabetes
The Impact of Finerenone Plus Empagliflozin on Hyperkalemia in the CONFIDENCE Trial
NephrologyThe Impact of Finerenone Plus Empagliflozin on Hyperkalemia in the CONFIDENCE Trial
AIP Emerges as a Potential Marker for Diabetic Kidney Risk
Clinician's RoundtableAIP Emerges as a Potential Marker for Diabetic Kidney Risk
Pediatric Psoriasis in Focus: Emerging Insights on Immune and Obesity Drivers
On the Frontlines of PsoriasisPediatric Psoriasis in Focus: Emerging Insights on Immune and Obesity Drivers
- advertisement
Linking Obesity to Alzheimer’s: The Lipid Signals Driving Neurodegeneration
Clinician's RoundtableLinking Obesity to Alzheimer’s: The Lipid Signals Driving Neurodegeneration
Screening for Prediabetes in Youth with Obesity: Evaluating the TyG Index
Clinician's RoundtableScreening for Prediabetes in Youth with Obesity: Evaluating the TyG Index
Obesity and Cancer Screening: National Trends and Disparities Revealed
Clinician's RoundtableObesity and Cancer Screening: National Trends and Disparities Revealed
Lifestyle Intervention and Bone Quality in Older Adults with Obesity
Clinician's RoundtableLifestyle Intervention and Bone Quality in Older Adults with Obesity
Identifying Hidden Risk: Metabolomic Patterns in Childhood Obesity
Clinician's RoundtableIdentifying Hidden Risk: Metabolomic Patterns in Childhood Obesity
EASD Highlights: Prediabetes Diagnosis, Prevalence, Misclassification Risks, and the Potential for Remission
Diabetes and EndocrinologyEASD Highlights: Prediabetes Diagnosis, Prevalence, Misclassification Risks, and the Potential for Remission
- advertisement
Managing Cholesterol and Triglyceride Levels: Targeted Nutritional Approaches
Heart MattersManaging Cholesterol and Triglyceride Levels: Targeted Nutritional Approaches
Risk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
Eye on Ocular HealthRisk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
PRP Scaffolds in Chronic Wound Care: A Move Toward Regenerative Solutions
Clinician's RoundtablePRP Scaffolds in Chronic Wound Care: A Move Toward Regenerative Solutions
